NewsRx

Search our medical news database

HIV/AIDS Diagnostics

HIV antibody/antigen assays perform better than antibody-only assays

Published in Blood Weekly, March 10th, 2005

HIV antibody/antigen assays perform better than antibody-only assays.

"In this study, we evaluated the performance of six HIV combined p24 antigen and antibody (Ag/Ab) assays versus two third-generation anti-HIV antibody assays.

"The assays were evaluated using p24 antigen panel of 31 HIV-1 subtypes (n=124), 25 HIV-1 seroconversion panels (n=176) HIV-1 antibody positive samples including group M subtypes and group 0 (n=559), HIV-2 positive samples (n=110), and unselected HIV negative samples from four French private laboratories (n=1005)," researchers in France report.

"The results showed that, overall, HIV combined Ag/Ab assays...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook